BlackRock Health Sciences Opportunities Portfolio Service Shares
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SHISX research report →
Price Chart
About the company
This investment vehicle aims to achieve long-term capital appreciation for its shareholders. It primarily allocates a minimum of 80% of its total assets to equities, predominantly common stock, of companies operating in the health sciences sector and associated industries. This encompasses businesses involved in areas such as healthcare equipment and supplies, service providers, biotechnology, and pharmaceuticals.
- IPO
- 2005
- HQ
- Wilmington, DE, US
Get TickerSpark's AI analysis on SHISX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $6.58B
- P/E
- 3853.92
- PEG
- 38.54
- P/S
- 338.03
- P/B
- 165.41
- EV/EBITDA
- 56278.77
- Div Yield
- 14.49%
- Gross Margin
- 1.28%
- Op Margin
- 1.09%
- Net Margin
- 1.08%
- ROE
- 5.00%
- ROIC
- 4.20%
Latest fiscal year · YoY change
- Revenue
- $1.87B-3.1%
- Gross Profit
- $23.90M-54.4%
- Op Income
- $20.40M
- Net Income
- $20.15M-53.8%
- EPS
- $1.63-60.5%
- OCF Growth
- -57.3%
- FCF Growth
- -95.5%
- 52W High
- $70.24
- 52W Low
- $59.85
- 50D MA
- $64.55
- 200D MA
- $64.37
- Beta
- 0.51
- RSI (14)
- 54
- Avg Volume
- 0
No earnings-call transcripts are available for SHISX yet.
- Free Float
- 0.0%
- Shares Outstanding
- 100.54M
- Float Shares
- 0
Our SHISX coverage
Recent articles, reports, and earnings notes.
No research on SHISX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate SHISX report →